bioRxivCancer BiologyPreprint
The Cancer Testes Antigen, HORMAD1, is a Tumor-Specific Replication Fork Protection Factor
L. Herrera, K. McGlynn, Z. Gibbs, A. J. Davis, A. Whitehurst
Abstract
Tumors frequently activate the expression of genes that are only otherwise required for meiosis. HORMAD1, which is essential for meiotic recombination in multiple species, is expressed in over 50% of human lung adenocarcinoma cells (LUAD). We previously found that HORMAD1 promotes DNA double strand break (DSB) repair in LUAD. Here, we report that HORMAD1 takes on an additional role in protecting genomic integrity. Specifically, we find HORMAD1 is critical for protecting stalled DNA replication forks in LUAD. Loss of HORMAD1 leads to nascent DNA degradation, an event which is mediated by the MRE11-DNA2-BLM pathway. Moreover, following exogenous induction of DNA replication stress, HORMAD1 deleted cells accumulate single stranded DNA (ssDNA). We find that these phenotypes are the result of a lack of RAD51 and BRCA2 loading onto stalled replication forks. Ultimately, loss of HORMAD1 leads to increased DSBs and chromosomal aberrations in response to replication stress. Collectively, our data support a model where HORMAD1 expression is selected to mitigate DNA replication stress, which would otherwise induce deleterious genomic instability.
- organism: human
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: cancer & tumor microenvironment
- research focus: chromatin & epigenetic regulation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distinct complexes of RAD51 paralogs participate in different fork protection pathways
Debanjali Bhattacharya, Harsh Kumar Dwivedi, … Ganesh Nagaraju·bioRxiv·May 4, 2026
- SMARCAD1 Mediated Active Replication Fork Stability Maintains Genome Integrity
C. Lo, M. van Toorn, … N. Taneja·bioRxiv·Oct 5, 2020
- Rad51 is a druggable target that sustains replication fork progression upon DNA replication stress
S. Feu, F. Unzueta, … N. Agell·bioRxiv·Mar 25, 2022
- Disparate requirements for RAD54L in replication fork reversal
M. E. Uhrig, N. Sharma, … C. Wiese·bioRxiv·Jul 26, 2023
- In vivo inactivation of RAD51-mediated homologous recombination leads to premature aging, but not to tumorigenesis
G. Matos-Rodrigues, V. Barroca, … B. S. Lopez·bioRxiv·Jan 17, 2022
- BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair
Pei Xin Lim, Mahdia Zaman, … Maria Jasin·Molecular CellPeer-reviewed·Jan 19, 2024